Potassium Ion

Potassium Ion

SCHEMBL6928318

CCCCCCCCCCCCCCCCc1ccccc1S(=O)(=O)[O-].[K+]

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.53
NR1H2 P55055 1/20 0.44
NR1H3 Q13133 1/20 0.44
KCNH2 Q12809 6/20 0.42
BID P55957 3/20 0.42
MCL1 Q07820 3/20 0.42
BCL2L1 Q07817 2/20 0.42
BAK1 Q16611 2/20 0.42
KAT8 Q9H7Z6 2/20 0.42
PPARG P37231 1/20 0.42
PPARA Q07869 1/20 0.42
EP300 Q09472 1/20 0.42
KAT2A Q92830 1/20 0.42
KAT2B Q92831 1/20 0.42
KAT5 Q92993 1/20 0.42
SAE1 Q9UBE0 1/20 0.42
THRA P10827 1/20 0.41
THRB P10828 1/20 0.41
RECQL P46063 1/20 0.41
CYSLTR2 Q9NS75 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL2136189 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL5702137 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL5701984 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL4651734 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL5269687 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL23749193 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL8507014 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL3213706 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL21822103 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID
Potassium Ion SCHEMBL5694814 1.00 LIPG (0.53) LIPGNR1H2NR1H3KCNH2BID

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112831364-B Resin-based composite material water-based release agent and preparation method thereof 烟台大学 2022-07-01 CN claimed
CN-112831364-A Resin-based composite material water-based release agent and preparation method thereof 烟台大学 2021-05-25 CN claimed
CN-110819331-A Intelligent oil displacement agent capable of identifying oil and water and preparation method thereof 西安石油大学 2020-02-21 CN claimed
US-4914147-A TREAD COMPOSED OF SPECIFIC MODIFIED BUTADIENE-STYRENE RUBBER BLENDED WITH SPECIFIC CARBON BLACK, DIFFERENT RUBBER BRIDGESTONE CORPORATION (JP) 1990-04-03 US claimed
US-4139690-A ORGANOLITHIUM INITIATOR, ANIONIC SURFACTANT, LEWIS BASE JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1979-02-13 US claimed
EP-4108708-B1 METHOD FOR PRODUCING LATEX COMPOSITION ZEON CORP (JP) 2026-05-20 EP disclosed
EP-3632977-B9 POLYOLEFIN RESIN MODIFIER, POLYOLEFIN RESIN COMPOSITION, MODIFIED POLYOLEFIN RESIN FILM, AND LAMINATED FILM TAKEMOTO OIL & FAT CO LTD (JP) 2026-04-22 EP disclosed
EP-4112264-B1 METHOD FOR PRODUCING DIP-MOLDED ARTICLE ZEON CORP (JP) 2026-04-01 EP disclosed
EP-3862392-B1 MODIFIER FOR POLYOLEFIN RESIN TAKEMOTO OIL & FAT CO LTD (JP) 2026-01-28 EP disclosed
US-12528935-B2 Latex composition for dip molding and dip-molded article ZEON CORPORATION (JP) 2026-01-20 US disclosed
US-20260015448-A1 MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME, POLYMER COMPOSITION, CROSSLINKED PRODUCT, AND TIRE ENEOS MATERIALS CORPORATION (JP) 2026-01-15 US disclosed
US-12522577-B2 Method for producing organic compound M. TECHNIQUE CO., LTD. (JP) 2026-01-13 US disclosed
US-4419525-A OXIDATION OF OLEFINS TO KETONES, PALLADIUM, HETEROPOLYACID, SURFACTANT PHILLIPS PETROLEUM COMPANY (US) 1983-12-06 US disclosed
US-4299998-A Preparation of ethers PHILLIPS PETROLEUM CO. (US) 1981-11-10 US disclosed
US-4237331-A SEPARATING ISOBUTYLENES FROM AN OLEFIN STREAM BY FORMING CARBONYL COMPOUNDS IN THE PRESENCE OF A CATALYST COMPRISING A PALLADIUM COMPONENT, A COPPER COMPONENT AND A BORIC ACID PHILLIPS PETROLEUM COMPANY (US) 1980-12-02 US disclosed
US-4220604-A CONVERSION OF ISOOLEFIN TO KETONE PHILLIPS PETROLEUM COMPANY (US) 1980-09-02 US disclosed
US-4203927-A A TWO-PHASE AQUEOUS DILUENT, A CATALYST OF PALLADIUM, COPPER AND BORON COMPOUNDS, AND A SURFACTANT TO PRODUCE A CARBONYL COMPOUND PHILLIPS PETROLEUM COMPANY (US) 1980-05-20 US disclosed
US-4152354-A OLEFIN OXIDATION PROCESS PHILLIPS PETROLEUM COMPANY (US) 1979-05-01 US disclosed
US-4139690-A ORGANOLITHIUM INITIATOR, ANIONIC SURFACTANT, LEWIS BASE JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1979-02-13 US disclosed
EP-0000143-A1 Olefin oxidation process PHILLIPS PETROLEUM COMPANY (US) 1979-01-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528935-B2 Latex composition for dip molding and dip-molded article GLO1, WDR1, PIM1 LIPG 955/4885NR1H2 4450/4885NR1H3 4424/4885
US-20260015448-A1 MODIFIED CONJUGATED DIENE POLYMER AND METHOD FOR PRODUCING SAME, POLYMER COMPOSITION, CROSSLINKED PRODUCT, AND TIRE TRRAP, MALT1, CCT4 LIPG 3722/4885NR1H2 883/4885NR1H3 840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.